Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against ...
Ecumicin | C83H134N14O17 | CID 101894301 - PubChem
Structure of native ecumicin 175. | Download Scientific Diagram
Structures of cyclomarin A (CYMA) and ecumicin (ECU). | Download ...
ecumicin | Semantic Scholar
ClpC1 Activators. (a) Chemical structures of cymA, ecumicin and ...
Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin ...
RCSB PDB - 6PBS: Structure of ClpC1-NTD in complex with Ecumicin
(PDF) The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against ...
ClpC1 Activators. (a) Chemical structures of cymA, ecumicin and...
Structures of ecumycin (19) and rufomycin derivative (20): inhibitors ...
(IUCr) Structure of the N-terminal domain of ClpC1 in complex with the ...
(PDF) High-resolution structure of ClpC1-rufomycin and ligand binding ...
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M ...
Figure 1 from Discovery and characterization of the tuberculosis drug ...
Structure of the N-terminal domain of ClpC1 in complex with the ...
Cycloheptapeptides with promise as Anti-TB drug leads | Institute for ...
(PDF) Structure of the N-terminal domain of ClpC1 in complex with the ...
Improvement of the productivity of ecumicin, a novel anti-tuberculosis ...
Computer‐assisted 1H NMR analysis of the anti‐tuberculosis drug lead ...
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival ...
Structure-Based Drug Discovery | Institute for Tuberculosis Research ...
Rufomycin (RUF) analogues. a MIC against M. tuberculosis. | Download ...
In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and ...
Structure of the drug target ClpC1 unfoldase in action provides ...
Table 1 from Structure of the N-terminal domain of ClpC1 in complex ...
P200f22 Assignment 03 - Uasudashd - Development of the anti ...
Computer‐assisted 1 H NMR analysis of the anti‐tuberculosis drug lead ...
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies ...
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 ...
Structure-Based Analysis of Semisynthetic Anti-TB Rufomycin Analogues ...
Advanced Materials Technologies: Vol 7, No 11
The antibiotic cyclomarin blocks arginine-phosphate–induced millisecond ...
Bioautography with TLC-MS/NMR for Rapid Discovery of Anti-tuberculosis ...
Metabolites from Streptomyces aureus (VTCC43181) and Their Inhibition ...
Characterization of the Ohmyungsamycin Biosynthetic Pathway and ...
Tuberculosis Drug Discovery and Diagnosis Virtual Issue
Drug Target Validation in Polyamine Metabolism and Drug Discovery ...
Pharmacognosy Institute (PHCI) | University of Illinois Chicago
Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A ...
생체효능검증센터, BIO KOREA 2022서 화학요법 유발 신경병증성 통증 치료제 '항결핵 선도 화합물' 선보인다
Protein targets in Mycobacterium tuberculosis and their inhibitors for ...
World TB Day: A New Clue Offers Hope Against The Deadliest Infection ...
ClpC1 protein, Mycobacterium tuberculosis | Semantic Scholar
| Mechanism of action of different Clp protease inhibitors and ...
ESKAPE Pathogens: Looking at Clp ATPases as Potential Drug Targets
[보고서]Protein splicing 기법을 이용한 결핵균 ClpC1을 표적으로 하는 우수 cyclic peptide 제조 및 ...
New study shows promise against drug-resistant TB | arabtimes
Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis ...
(PDF) High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding ...
Tackling the global tuberculosis crisis: An emerging class of ...
Emerging class of antibiotics to tackle global tuberculosis crisis ...
Ecubectedin (PM14) | Antimicrobial Agent | MedChemExpress
Structures of compounds targeting Clp ATPases. Shown are the structures ...
Total Synthesis of Ecumicin,Organic Letters - X-MOL
[보고서]ClpC1 표적 기반 합리적 항결핵제 개량 및 개발
Frontiers | Currently Available Strategies for Target Identification of ...
Echinomycin | HIF-1 DNA-binding inhibitor | CAS NO.:512-64-1 | GlpBio
NPAs bound the to the N-terminal Domain of the Mtb ClpC1 ATPase. (A ...
Activity of RUFI against M. tuberculosis in murine macrophages. Bars ...
Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial ...
Anti-tuberculosis lead molecules from natural products targeting ...
BacPROTACs mediate targeted protein degradation in bacteria: Cell
Antimycobacterial activity of compounds against Mtb H37Rv virulent ...
